摘要
癌症是体内细胞失控生长,被认为是全球死亡的主要原因之一。有几种化疗药物如氨甲喋呤、5-氟尿嘧啶、顺铂、阿霉素和他莫昔芬等用于治疗癌症。虽然我们已经花费了数十亿美元用研究开发癌症化疗药物,它仍然是人类主要的疾病,部分原因是由于这些疗法的缺点。这些缺点包括靶向特异性低,严重的副作用(由于高剂量)和不足的药代动力学。为了避免这些缺点,抗癌药物传递系统已利用纳米载体包括脂质体,胶束聚电解质胶囊和其他载体。一最近研究用于化疗的纳米粒子的几类金属有机骨架(MOFs)是一种由金属离子和有机配体所组成的聚合物。MOFs材料已应用于气体分离、气体储存、催化、发光材料、生物医学成像等诸多领域。这些结构还有其他的功能,促进其作为药物载体在生物医学领域的使用。首先,他们是无毒的,可生物降解的,由于其多孔性而能进行高负荷的抗肿瘤剂。此外,他们有明确的晶体结构,其特征在于可以通过不同的分析技术,它们的大小是合适的,以控制其在体内的药物释放。 本文综述了合成MOFs的新方法以及其作为抗肿瘤药物载体的新应用。
关键词: 癌症,化疗,金属有机骨架(MOFs),加载,释放细胞毒性。
Current Medicinal Chemistry
Title:Anti-cancer Drug Delivery Using Metal Organic Frameworks (MOFs)
Volume: 24 Issue: 2
Author(s): Mihad Ibrahim, Rana Sabouni, Ghaleb A. Husseini.
Affiliation:
关键词: 癌症,化疗,金属有机骨架(MOFs),加载,释放细胞毒性。
摘要: Cancer is the uncontrolled growth of cells in the body and is considered as one of the major causes of death globally. There are several cytotoxic chemotherapeutic agents used to treat cancer including methotrexate, 5-fluorouracil, cisplatin, tamoxifen, doxorubicin and others. Although billions of dollars have been spent on cancer research to develop these chemotherapies, it still remains a major illness for mankind partly due to the shortcomings of these therapies. These shortcomings include low targeting specificity, severe side effects (due to high doses) and poor pharmacokinetics. To avoid these drawbacks, anti-cancer drug delivery systems have been developed recently using nanocarriers including liposomes, micelles, polyelectrolyte capsules and others.
One of the recent class of nanoparticles investigated for chemotherapeutic use are metal organic frameworks (MOFs) which are hybrid polymers that consist of metal ions or clusters and organic ligands. MOFs are used in many applications including gas/vapor separation, gas storage, catalysis, luminescent materials, and biomedical imaging. These structures have additional features that promote their use as drug carriers in the biomedical field. First, they are nontoxic, biodegradable and have the ability to carry high loadings of the anti-neoplastic agent due to their porous nature. Also, they have well-defined crystalline structures that can be characterized by different analytical techniques and their sizes are suitable to control their in vivo drug release.
This paper reviews the methods used to synthesize MOFs and their recent use as antineoplastic drug delivery carriers.
Export Options
About this article
Cite this article as:
Mihad Ibrahim, Rana Sabouni, Ghaleb A. Husseini. , Anti-cancer Drug Delivery Using Metal Organic Frameworks (MOFs), Current Medicinal Chemistry 2017; 24 (2) . https://dx.doi.org/10.2174/0929867323666160926151216
DOI https://dx.doi.org/10.2174/0929867323666160926151216 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Vitiligo: Pathogenetic Hypotheses and Targets for Current Therapies
Current Drug Metabolism Beyond the "Lock and Key" Paradigm: Targeting Lipid Rafts to Induce the Selective Apoptosis of Cancer Cells
Current Medicinal Chemistry Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
Current Cancer Drug Targets Antiviral Effects of Saffron and its Major Ingredients
Current Drug Delivery Mast Cells in Allergic and Inflammatory Diseases
Current Pharmaceutical Design Kinetics of Interaction of HLA-B2705 with Natural Killer Cell Immunoglobulin- Like Receptor 3DS1
Protein & Peptide Letters Novel Vaginal Drug Delivery Systems: A Review
Current Drug Therapy Carotenoids and Modulation of Cancer: Molecular Targets
Current Pharmacogenomics Stem Cell and Regenerative Medicine
Current Stem Cell Research & Therapy Novel Mechanisms of Anticancer Activities of Green Tea Component Epigallocatechin- 3-Gallate
Anti-Cancer Agents in Medicinal Chemistry Critical Role of Hypoxia Sensor - HIF-1α in VEGF Gene Activation. Implications for Angiogenesis and Tissue Injury Healing
Current Medicinal Chemistry Therapeutic Strategies for Targeting BRAF in Human Cancer
Reviews on Recent Clinical Trials Design, Synthesis and Biological Evaluation of 4, 6-Coumarin Derivatives as Anti- Cancer and Apoptosis-Inducing Agents
Anti-Cancer Agents in Medicinal Chemistry Cellular FLICE-Like Inhibitory Protein (C-FLIP): A Novel Target for Cancer Therapy
Current Cancer Drug Targets Synthesis and Anti – Tumour Activity of Novel Camptothecin – Bile Acid Analogues
Letters in Drug Design & Discovery Reversing Aberrant Methylation Patterns in Cancer
Current Medicinal Chemistry A Critical Transcription Factor NF-κB as a Cancer Therapeutic Target and its Inhibitors as Cancer Treatment Options
Current Medicinal Chemistry <i>Taraxacum officinale</i> Extracts Exhibit Safe and Selective Anticancer Activity
The Natural Products Journal microRNAs-based Predictor Factor in Patients with Migraine-ischemic Stroke
MicroRNA Cyclophilin function in Cancer; lessons from virus replication
Current Molecular Pharmacology